We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

MNCH Programming in Southwest Uganda Maternal and Child Health In Bushenyi and Rubirizi Districts, UGANDA (HCUM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01571765
Recruitment Status : Completed
First Posted : April 5, 2012
Last Update Posted : May 6, 2015
Canadian International Development Agency
Information provided by (Responsible Party):
Jennifer L. Brenner, University of Calgary

Brief Summary:

The investigators will assess whether in Bushenyi District in southwestern Uganda, a two year intervention providing comprehensive MNCH programming will:

  • Reduce morbidity and mortality for children under five years old and;
  • Improve access to maternal health services Compared to a control community without MNCH intervention?


Comprehensive maternal, newborn and child health programming in Bushenyi Distrcit can have a positive impact on morbidity and mortality for children under five years and will improve access for women to maternal health services which may lead, in the longer term, to decreased maternal mortality.

Condition or disease Intervention/treatment
Child Mortality Maternal Mortality (All Cause) Other: MNCH programming in health district

Detailed Description:

A detailed impact assessment will be carried out for the duration of the MNCH training and support initiative in Bushenyi District, using mixed methods. The study will assess 8 of the 11 key core MNCH indicators as identified by CIDA as a priority. Other information to be collected such as demographics and patterns of health care use, and prevalence of disease will help health planners in the districts, and will be helpful in sub analysis and interpretation of findings. The main study will use household surveys in both districts at baseline, midline and endline. Other tools will include pre and post qualitative surveys (FGDs, KII) and analysis of operational data.

The main study group will be representative communities and health centres within Bushenyi District who will receive intervention between 2012 and 2014; Rubirizi District will serve as a control area for this study but will received selected MNCH services starting in 2013 after midline data are collected.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 10985 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Scaling Up Maternal and Child Health In Bushenyi and Rubirizi Districts, UGANDA
Study Start Date : April 2012
Primary Completion Date : July 2014
Study Completion Date : March 2015

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: MNCH programming
protocols and training for data collection, referrals, and management for health district. Training in obstetrics, newborn care and management of sick children for health workers, Increased community health promotion such as training of CHWs, health centre management teams and bednet distribution
Other: MNCH programming in health district
training at health district level in management, data collection. Training at health centres in obstetrics and pediatrics and training in community of CHWs and bednet distribution
No Intervention: no added MNCH activities

Primary Outcome Measures :
  1. Reduced morbidity for children under five years old [ Time Frame: 2 years ]

Secondary Outcome Measures :
  1. improved maternal access to health services [ Time Frame: 24 months ]
    proportion of pregnant women who have attended antenatal care four or more times; proportion of women whose most recent delivery was attended by a skilled birth attendant; met need for contraception (CIDA indicator)

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   15 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • all households living in selected communities; all women 15-49 living in selected communities Exclusion Criteria: none

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01571765

Mbarara University of Science and Technology
Mbarara, Uganda
Sponsors and Collaborators
University of Calgary
Canadian International Development Agency
Principal Investigator: Jennifer Brenner, MD University of Calgary
Principal Investigator: Jerome Kabakyenga, MBBS, PHD Mbarara University of Science and Technology

Responsible Party: Jennifer L. Brenner, Clinical Associate Professor, University of Calgary
ClinicalTrials.gov Identifier: NCT01571765     History of Changes
Other Study ID Numbers: CIDA S-065346
First Posted: April 5, 2012    Key Record Dates
Last Update Posted: May 6, 2015
Last Verified: May 2015

Keywords provided by Jennifer L. Brenner, University of Calgary:

Additional relevant MeSH terms:
Maternal Death
Pregnancy Complications
Parental Death
Pathologic Processes